American Oncology Network Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Cash & Equivalents	28.54	26.93	32.35	0
Short-Term Investments	36.99	11.65	1.81	0
Cash & Cash Equivalents	65.53	38.57	34.17	0
Cash Growth	69.89%	12.90%	-	-
Receivables	163.43	164.3	136.3	0
Inventory	44.57	36.48	34.53	0
Other Current Assets	4.28	2.67	3.28	0
Total Current Assets	277.8	242.02	208.28	0
Property, Plant & Equipment	83.79	75.7	32.65	0
Long-Term Investments	1.15	2.08	3.15	0
Goodwill and Intangibles	1.23	1.23	1.11	0
Other Long-Term Assets	10.48	5.2	3.11	0.01
Total Long-Term Assets	96.65	84.21	40.02	0.01
Total Assets	374.45	326.23	248.3	0.01
Accounts Payable	127.65	106.5	92.91	0.01
Deferred Revenue	0	0	3.74	0
Current Debt	6.69	9.18	0	0
Other Current Liabilities	34.71	25.27	22.69	0
Total Current Liabilities	169.05	140.94	119.34	0.01
Long-Term Debt	120.44	117.53	63.69	0
Other Long-Term Liabilities	14.25	5.75	5.72	0
Total Long-Term Liabilities	134.7	123.27	69.41	0
Total Liabilities	303.74	264.21	188.75	0.01
Total Debt	127.14	126.7	63.69	0
Debt Growth	0.34%	98.92%	-	-
Retained Earnings	-161.81	25.83	23.24	-0
Comprehensive Income	0.08	-0.12	0	0
Shareholders' Equity	-161.73	62.02	59.54	-0
Net Cash / Debt	-61.6	-88.13	-29.53	0
Net Cash Per Share	-9.21	-11.41	-3.82	-
Working Capital	108.76	101.08	88.93	-0.01
Book Value Per Share	-24.19	8.03	7.71	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).